Akèy › Sipwa › Florid › Deltona
Etid klinik pou Sipwa nan Deltona, FL
9 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Deltona (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 2
- Progressive Medical Research /ID# 282838, Port Orange · 23 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- Adult Medicine of Lake County, Inc., Mt. Dora · 24 mi lwen
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Velocity Clinical Research - New Smyrna Beach, Edgewater · 23 mi lwen
- Progressive Medical Research, Port Orange · 23 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Adult Medicine of Lake County, Inc., Mt. Dora · 24 mi lwen
- Arrow Clinical Trials, Daytona Beach · 26 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Daytona Beach · 26 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Daytona Beach · 26 mi lwen
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- Progressive Medical Research, Port Orange · 23 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Orange City · 4 mi lwen
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Progressive Medical Research, Port Orange · 23 mi lwen
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- Washington, DC19 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Austin, TX18 etid
Lòt etid nan Deltona
- Kansè Poumon ki pa ti selil15 etid
- Obèsite11 etid
- Dyabèt Tip 210 etid
- Maladi Alzheimer10 etid
- Kansè poumon8 etid
- Kansè nan tete8 etid
- Kansè (tout kalite)7 etid
- Osteoartrit jenou5 etid
- Kansè Metastatik5 etid
- Melanom5 etid
- Hypertension artérielle5 etid
- Maladi kadyovaskilè4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.